Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.

Chak A, Lee T, Kinnard MF, Brock W, Faulx A, Willis J, Cooper GS, Sivak MV Jr, Goddard KA.

Gut. 2002 Sep;51(3):323-8.

2.

Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.

Lord RV, Frommer DJ, Inder S, Tran D, Ward RL.

Aust N Z J Surg. 2000 Jan;70(1):26-33. Review.

PMID:
10696939
3.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

4.

Review: Barrett's oesophagus in Taiwan.

Chen PH.

J Gastroenterol Hepatol. 1997 Jun;12(6):S19-22. Review.

PMID:
9195407
5.

Malignant Barrett's oesophagus.

Li H.

Eur J Cancer Prev. 1993 Jan;2(1):47-52. Review.

PMID:
8428176
6.

Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.

Sharma P.

Aliment Pharmacol Ther. 2004 Oct;20 Suppl 5:48-54; discussion 61-2. Review.

7.

Barrett's oesophagus: treatment with surgery.

DeMeester SR.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):211-7. doi: 10.1016/j.bpg.2014.12.004. Epub 2014 Dec 18. Review.

PMID:
25743467
8.
9.

Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.

Roman S, Kahrilas PJ.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):17-28. doi: 10.1016/j.bpg.2014.11.002. Epub 2014 Nov 12. Review.

10.

Gastro-oesophageal reflux: the disease of the millennium.

Navaratnam RM, Winslet MC.

Hosp Med. 1998 Aug;59(8):646-9. Review.

PMID:
9829061
11.

Pathophysiological characteristics of long- and short-segment Barrett's oesophagus.

Zentilin P, Reglioni S, Savarino V.

Scand J Gastroenterol Suppl. 2003;(239):40-3. Review.

PMID:
14743882
12.

Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.

Souza RF, Morales CP, Spechler SJ.

Aliment Pharmacol Ther. 2001 Aug;15(8):1087-100. Review.

13.

Review article: Barrett's oesophagus and carcinoma in Japan.

Hongo M.

Aliment Pharmacol Ther. 2004 Dec;20 Suppl 8:50-4. Review.

14.

Should patients with Barrett's oesophagus be kept under surveillance? The case for.

Armstrong D.

Best Pract Res Clin Gastroenterol. 2008;22(4):721-39. doi: 10.1016/j.bpg.2008.03.002. Review.

PMID:
18656826
16.

Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.

Fitzgerald RC, Lascar R, Triadafilopoulos G.

Aliment Pharmacol Ther. 2001 Mar;15(3):269-76. Review.

17.

Prognostic value of p53 in Barrett's oesophagus.

Krishnadath KK, van Blankenstein M, Tilanus HW.

Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81-4. Review.

PMID:
7866817
18.

Should patients with Barrett's oesophagus be kept under surveillance? The case against.

Barritt AS 4th, Shaheen NJ.

Best Pract Res Clin Gastroenterol. 2008;22(4):741-50. doi: 10.1016/j.bpg.2007.12.005. Review.

PMID:
18656827
19.

Acid suppression and surgical therapy for Barrett's oesophagus.

de Jonge PJ, Spaander MC, Bruno MJ, Kuipers EJ.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):139-50. doi: 10.1016/j.bpg.2014.11.005. Epub 2014 Nov 12. Review.

PMID:
25743462
20.

Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.

Rubenstein JH, Thrift AP.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):41-50. doi: 10.1016/j.bpg.2014.11.009. Epub 2014 Dec 3. Review.

PMID:
25743455

Supplemental Content

Support Center